Updates are available Correction dated 2025-01-09
Click to view Correction: https://doi.org/10.1038/s41586-024-08560-0
-
Authors
Moorman, Andrew
Benitez, Elizabeth K.
Cambulli, Francesco
Jiang, Qingwen
Mahmoud, Ahmed
Lumish, Melissa https://orcid.org/0000-0003-4173-5567
Hartner, Saskia https://orcid.org/0009-0006-1030-1191
Balkaran, Sasha https://orcid.org/0000-0001-9991-6649
Bermeo, Jonathan https://orcid.org/0000-0002-9553-9222
Asawa, Simran https://orcid.org/0000-0001-9015-254X
Firat, Canan
Saxena, Asha https://orcid.org/0000-0002-3410-4436
Wu, Fan https://orcid.org/0000-0002-3960-320X
Luthra, Anisha
Burdziak, Cassandra
Xie, Yubin
Sgambati, Valeria
Luckett, Kathleen
Li, Yanyun
Yi, Zhifan
Masilionis, Ignas
Soares, Kevin https://orcid.org/0000-0002-0406-017X
Pappou, Emmanouil https://orcid.org/0000-0002-8735-1852
Yaeger, Rona https://orcid.org/0000-0002-7233-5454
Kingham, T. Peter
Jarnagin, William
Paty, Philip B. https://orcid.org/0000-0002-7045-2112
Weiser, Martin R. https://orcid.org/0000-0002-9577-7984
Mazutis, Linas https://orcid.org/0000-0002-5552-6427
D’Angelica, Michael
Shia, Jinru https://orcid.org/0000-0002-4351-2511
Garcia-Aguilar, Julio https://orcid.org/0000-0003-2451-0948
Nawy, Tal https://orcid.org/0000-0003-3720-3699
Hollmann, Travis J. https://orcid.org/0000-0003-4332-3291
Chaligné, Ronan
Sanchez-Vega, Francisco
Sharma, Roshan
Pe’er, Dana https://orcid.org/0000-0002-9259-8817
Ganesh, Karuna https://orcid.org/0000-0002-4948-1082
- License Information
-
More Information
Article History
Received: 10 July 2023
Accepted: 2 October 2024
First Online: 30 October 2024
Change Date: 9 January 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41586-024-08560-0
Competing interests
: K.G. is listed as an inventor on US patent 11,464,874, and US provisional patent applications 63/478,809 and 63/478,829 on targeting L1CAM to treat cancer, submitted by MSKCC. D.P. is on the scientific advisory board of Insitro. J.S. is a consultant for Paige AI. R.Y. has served on the advisory board for Pfizer, Mirati Therapeutics, Revolution Medicine, Loxo@Lilly and Amgen, received a speaker’s honorarium from Zai Lab, and has received research support from Pfizer, Boehringer Ingelheim, Mirati Therapeutics, Daiichi Sankyo, FogPharma and Boundless Bio. J.G.-A. owns stock in Intuitive Surgical. R.C. is a consultant for Sanavia Oncology, S2 Genomics and LevitasBio. The other authors declare no competing interests.
